Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
207,440,936
-
Total 13F shares
-
15,304,049
-
Share change
-
+2,383,293
-
Total reported value
-
$1,251,247,346
-
Put/Call ratio
-
39%
-
Price per share
-
$81.76
-
Number of holders
-
150
-
Value change
-
+$182,794,461
-
Number of buys
-
112
-
Number of sells
-
60
Institutional Holders of Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) as of Q2 2015
As of 30 Jun 2015,
Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) was held by
150 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,304,049 shares.
The largest 10 holders included
FMR LLC, Pentwater Capital Management LP, Viking Global Investors LP, GILDER GAGNON HOWE & CO LLC, Visium Asset Management, LP, VANGUARD GROUP INC, WASATCH ADVISORS INC, COLUMBUS CIRCLE INVESTORS, STATE STREET CORP, and Polar Capital LLP.
This page lists
150
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.